Prof Julian Hiscox BSc PhD

Chair in Infection and Global Health Infection Biology


    Research Interest 1

    Julian's laboratory focuses on elucidating how respiratory viruses and Ebola hemorrhagic fever virus interact with the host cell. The laboratory uses a combination of high throughput proteomics and functional assays to identify host cell proteins that are essential for virus biology. The idea being that these proteins would represent novel targets for transient anti-viral therapy. The main viruses understudy include those important for global health and food security. This includes a Medical Research Council (MRC) funded project on human respiratory syncytial virus and influenza A virus and funding from Public Health England to support research on emerging and hemorrhagic fever viruses. He works closely with Dr. John Barr at the University of Leeds Prof. Paul Digard at the Roslin Institute and Dr. David Matthews at the University of Bristol.

    Research Grants
    • EVIDENT - High throughput analysis of samples from the West African ebola outbreak
    • Health Protection Research Unit: Emerging Infections (including zoonoses) and Biological Threats.
    • EMBO Workshop on Integrating omic approaches to host pathogen interactions
    • Analysis of the function of infectious bronchitis virus accessory proteins - towards better vaccines
    • Zana Mahmood - bench fees
    • Waleed Al Jabr bench fees
    • Predicting Influenza severity by proteomics (PrInSeP).
    • The role of cellular RNA editing in human respiratory syncytial virus and influenza virus biology.
    Research Collaborations

    Dr. Roger Hewson and Prof. Miles Carroll

    External: Health Protection Agency

    Collaborate on emerging viral pathogens

    Prof. Paul Digard

    External: University of Edinburgh

    Collaborate on an MRC funded project looking at the interaction of human respiratory syncytial virus and influenza A virus with the host.

    Dr. John N. Barr

    External: University of Leeds

    Investigating respiratory and emerging pathogens on joint MRC and Health Protection Agency funded projects.

    Untitled Document